• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因甲基化和 WIF1 沉默是套细胞淋巴瘤中常见的遗传异常。

Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma.

机构信息

Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, P.O. Box 41477, Saudi Arabia.

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2E1, Canada.

出版信息

Int J Mol Sci. 2021 Jan 18;22(2):893. doi: 10.3390/ijms22020893.

DOI:10.3390/ijms22020893
PMID:33477402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830226/
Abstract

We have previously shown that the Wnt canonical pathway (WCP) is constitutively active in most cases of mantle cell lymphoma (MCL). Here, we aimed to elucidate the mechanisms underlying this biochemical deregulation. We hypothesized that gene methylation/silencing of WIF1 (Wnt inhibitory factor-1), a physiologic inhibitor of WCP, contributes to the deregulation of WCP and promotes cell growth in MCL. In support of this hypothesis, we found that the expression of WIF1 was detectable in none of the 4 MCL cell lines, and in only 2 of 5 tumors (40%) examined. Using methylation-specific PCR, we found evidence of gene methylation of WIF1 in 4 of 5 cell lines (80%) and in 24 of 29 (82%) tumors. The addition of the demethylation agent 5-aza-2'-deoxycytidine to Mino and JeKo-1, two WIF1-negative cell lines, restored the expression of WIF1 mRNA in these cells. Gene transfection of WIF1 into JeKo-1 and Mino cells significantly reduced cell growth, and this finding correlated with substantial downregulations of various proteins in WCP, such as β-catenin and pGSK-3β. In conclusion, our results support the concept that gene methylation/silencing of WIF1 is a frequent event in MCL, and this abnormality contributes to the aberrant activation of WCP. These results have provided further evidence that aberrant Wnt signaling is pathogenetically important in MCL and it may represent a potential therapeutic target.

摘要

我们之前已经表明,在大多数套细胞淋巴瘤(MCL)病例中,Wnt 经典途径(WCP)是持续激活的。在这里,我们旨在阐明这种生化失调的机制。我们假设 WIF1(Wnt 抑制因子-1)的基因甲基化/沉默,WCP 的一种生理性抑制剂,有助于 WCP 的失调,并促进 MCL 中的细胞生长。为了支持这一假说,我们发现 4 种 MCL 细胞系中均检测不到 WIF1 的表达,在 5 种肿瘤中仅有 2 种(40%)检测到。使用甲基化特异性 PCR,我们发现 5 种细胞系中的 WIF1 基因甲基化证据在 4 种(80%)和 29 种肿瘤中的 24 种(82%)中存在。在 WIF1 阴性的 Mino 和 JeKo-1 两种细胞系中添加去甲基化剂 5-aza-2'-脱氧胞苷,可恢复这些细胞中 WIF1 mRNA 的表达。WIF1 基因转染到 JeKo-1 和 Mino 细胞中显著降低了细胞生长,这一发现与 WCP 中的各种蛋白(如β-catenin 和 pGSK-3β)的显著下调相关。总之,我们的结果支持这样一种概念,即 WIF1 的基因甲基化/沉默是 MCL 中的一种常见事件,这种异常有助于 WCP 的异常激活。这些结果进一步证明了异常的 Wnt 信号在 MCL 中具有重要的发病机制作用,它可能代表一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/d159f95aa36e/ijms-22-00893-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/1fd2d1505c1e/ijms-22-00893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/32d0e03d38e4/ijms-22-00893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/562d6e92eacd/ijms-22-00893-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/6ece0a001228/ijms-22-00893-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/d159f95aa36e/ijms-22-00893-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/1fd2d1505c1e/ijms-22-00893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/32d0e03d38e4/ijms-22-00893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/562d6e92eacd/ijms-22-00893-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/6ece0a001228/ijms-22-00893-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a4/7830226/d159f95aa36e/ijms-22-00893-g005.jpg

相似文献

1
Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma.基因甲基化和 WIF1 沉默是套细胞淋巴瘤中常见的遗传异常。
Int J Mol Sci. 2021 Jan 18;22(2):893. doi: 10.3390/ijms22020893.
2
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.Wnt 抑制因子 1 诱导宫颈癌体内凋亡和生长抑制、侵袭和血管生成。
Oncogene. 2012 May 31;31(22):2725-37. doi: 10.1038/onc.2011.455. Epub 2011 Oct 17.
3
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.WIF1 是宫颈鳞状细胞癌中表观遗传沉默的常见靶点。
Carcinogenesis. 2011 Nov;32(11):1625-33. doi: 10.1093/carcin/bgr193. Epub 2011 Aug 26.
4
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.肿瘤抑制因子Wnt抑制因子1在鼻咽癌和食管癌中经常发生甲基化。
Lab Invest. 2007 Jul;87(7):644-50. doi: 10.1038/labinvest.3700547. Epub 2007 Mar 26.
5
WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.WIF1 启动子超甲基化通过 Wnt/β-连环蛋白信号通路诱导子宫内膜癌发生。
Am J Reprod Immunol. 2023 Aug;90(2):e13743. doi: 10.1111/aji.13743.
6
Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.WNT 抑制因子-1 启动子甲基化与 WNT/β-连环蛋白通路在人脑星形细胞瘤中的表达模式:病理与预后相关性。
Mod Pathol. 2013 May;26(5):626-39. doi: 10.1038/modpathol.2012.215. Epub 2013 Jan 18.
7
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.套细胞淋巴瘤中Wnt经典信号通路的组成性激活
Blood. 2008 Dec 15;112(13):5171-9. doi: 10.1182/blood-2008-02-139212. Epub 2008 Sep 11.
8
Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.Wnt 抑制因子-1 在人食管鳞癌中的表观遗传学失活。
Oncol Res. 2012;20(2-3):123-30. doi: 10.3727/096504012x13477145153039.
9
Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.通过表观遗传沉默使Wnt抑制因子1(WIF1)表达失活在乳腺癌中是常见现象。
Carcinogenesis. 2006 Jul;27(7):1341-8. doi: 10.1093/carcin/bgi379. Epub 2006 Feb 25.
10
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.Wnt 抑制因子 1(WIF1)甲基化及其与软骨肉瘤患者临床预后的关系。
Sci Rep. 2017 May 8;7(1):1580. doi: 10.1038/s41598-017-01763-8.

本文引用的文献

1
Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma.B 细胞受体信号转导稳定 β-连环蛋白促进套细胞淋巴瘤中 NF-κB 靶基因的转录。
Oncogene. 2020 Apr;39(14):2934-2947. doi: 10.1038/s41388-020-1183-x. Epub 2020 Feb 7.
2
WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.腹水 WNT 信号诱导活性可预测卵巢癌不良预后。
Theranostics. 2020 Jan 1;10(2):537-552. doi: 10.7150/thno.37423. eCollection 2020.
3
The double dealing of cyclin D1.细胞周期蛋白 D1 的两面性。
Cell Cycle. 2020 Jan;19(2):163-178. doi: 10.1080/15384101.2019.1706903. Epub 2019 Dec 29.
4
DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.SFRP1、SFRP2 和 WIF1 的 DNA 甲基化与结直肠癌患者术后的预后。
BMC Cancer. 2019 Dec 12;19(1):1212. doi: 10.1186/s12885-019-6436-0.
5
Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers.经典WNT/β-连环蛋白信号通路在癌症中的多个靶点
Front Oncol. 2019 Nov 18;9:1248. doi: 10.3389/fonc.2019.01248. eCollection 2019.
6
Gene promoter methylation and cancer: An umbrella review.基因启动子甲基化与癌症:伞式综述。
Gene. 2019 Aug 20;710:333-340. doi: 10.1016/j.gene.2019.06.023. Epub 2019 Jun 13.
7
Targeting the canonical Wnt/β-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms.靶向癌症放射抗性中的经典Wnt/β-连环蛋白信号通路:分子机制的最新进展
J Cancer Res Ther. 2019;15(2):272-277. doi: 10.4103/jcrt.JCRT_421_18.
8
Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis.肿瘤抑制基因的高甲基化是卵巢癌预后不良的一个危险因素:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(8):e14588. doi: 10.1097/MD.0000000000014588.
9
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options.异常的 Wnt 信号通路在多发性骨髓瘤中的作用:分子机制和靶向治疗选择。
Leukemia. 2019 May;33(5):1063-1075. doi: 10.1038/s41375-019-0404-1. Epub 2019 Feb 15.
10
An Eye on the Wnt Inhibitory Factor Wif1.关注Wnt抑制因子Wif1
Front Cell Dev Biol. 2018 Dec 6;6:167. doi: 10.3389/fcell.2018.00167. eCollection 2018.